124I-PUH-71

N/A

Report date: 2025/11/21 17:15:42

Base Information

Drug Name124I-PUH-71
Drug Alias Name124I-PU-H71124I-PUH-71PUH-71-[124I]Iodine -124-PUH-71
ClassificationSmall moleculesDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionHeat shock protein HSP90 modulators
TargetsHeat shock protein HSP90
Therapy Area/IndicationsSolid tumoursMyeloproliferative DisordersBone Marrow Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesMemorial Sloan Kettering Cancer Center
Inactive CompaniesN/A
Active IndicationsSolid tumoursMyeloproliferative DisordersBone Marrow Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A